This article and associated images are based on a poster originally authored by T. Ishigami, K. Terada, and N. Ichimura and presented at ELRIG Drug Discovery 2026 in affiliation with Zeon Corporation.
This poster is being hosted on this website in its raw form, without modifications. It has not undergone peer review but has been reviewed to meet AZoNetwork's editorial quality standards. The information contained is for informational purposes only and should not be considered validated by independent peer assessment.

Overview
Researchers have developed CELLAZIP™ coat-F and coat-G, ready-to-use COP* microplates coated with Zeon’s original coating materials for adherent cell culture and cell-based assays. CELLAZIP™ microplates are applicable to various types of cells, including general cell lines, primary cells, and neural cells. CELLAZIP™ has excellent storage stability at room temperature for 24 months.
* Cyclo Olefin Polymer (COP) is a thermoplastic resin developed by Zeon
Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
Features
Bottom flatness

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
Autofluorescence

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
Lot-to-lot variation

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
- Cell: iCell® GlutaNeurons (FUJIFILM Cellular Dynamics)
- Cell density: 16,000 cells/well
- Culture period: 14 days
- Plates: 384-well CELLAZIP™ coat-F
- Immunostaining: MAP2 (red)
No effect on neuron culture was observed among lots.
Storage performance

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
In the bar chart:
- Bar Ⅰ: 24 months storage at room temperature after coating
- Bar Ⅱ: Prepared just before use
Cell: HEK293 (ECACC), cell density: 10,000 cells/well
Culture period: Seven days
Plates: 96-well CELLAZIP™ coat-F
Cell staining: Calcein-AM (green)
The plates can be stored at room temperature for 24 months after coating.
Cells successfully cultured with CELLAZIP™
CELLAZIP™ coat-F. Source: Zeon Corporation
| CELLAZIP™ coat-F |
| hiPSC-derived |
Motor neurons GABAergic neurons Dopaminergic neurons Glutamatergic neurons, etc |
| Primary cells |
Rat hippocampal neuronal cells Rat cerebral cortex neuronal cells, etc |
| Cell line |
HEK293, HEK293T, U-2 OS, etc |
CELLAZIP™ coat-G. Source: Zeon Corporation
| CELLAZIP™ coat-G |
| hiPSC-derived |
Cardiomyocytes |
| Stem cells |
Mesenchymal stem cell |
| Primary cells |
Skeletal muscle cell |
| Cell line |
A549, MCF-7, PANC-1, HeLa, HepG2, SH-SY5Y, CALU-1, C2C12, MRC5, V79, etc |
Comparison between existing pre-coated microplates and CELLAZIP™

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
- iCell® DopaNeurons (FUJIFILM Cellular Dynamics): Cell density: 64,000 cells/well; Culture period: 14 days (n =12)
- iCell® Motor Neurons (FUJIFILM Cellular Dynamics): Cell density: 32,000 cells/well; Culture period: 14 days (n =18)
Plates: 96-well CELLAZIP™ coat-F, existing 96-well microplate precoated with Poly-D-lysine
Immunostaining: Synapsin1 (green), MAP2 (red), DAPI (blue)
Images: CellVoyager CQ1 (Yokogawa), 10x objective, scale bar = 100 μm

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
Cell: iCell® Cardiomyocytes2 (FUJIFILM Cellular Dynamics)
Cell density: 50,000 cells/well
Culture period: 28 days
Plates: 96-well CELLAZIP™ coat-G, existing 96-well microplate precoated with Fibronectin
Immunostaining: α-actinin2 (green); cardiac muscle troponin T (red); Hoechst (blue)
Images: CellVoyager CQ1 (Yokogawa)
Cell-based assay applications using CELLAZIP™

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd.
Cell: iCell ® GABANeurons (FUJIFILM Cellular Dynamics)
Cell density: 4500 cells/well
Plate: 384-well CELLAZIP™ coat-F
Assay workflow: On day one, compounds were added at concentrations ranging from 10 μM~4.57 nM (colchicine 1 μM~0.4 nM) (n = 5) and incubated for 72 hours.
Immunostaining: βⅢtubulin(green); F-actin (red); Hoechst (blue)
Images: CellVoyager CQ1 (Yokogawa), 40x objective, scale bar = 20 μm
Neurite length: Neurite lengths were quantified with βⅢtubulin using image analysis software (CellPathfinder, Yokogawa) using a 10x objective image.
Reference: doi:10.1242/dmm.031906

Image Credit: Image courtesy of T. Ishigami et al., in partnership with ELRIG (UK) Ltd
Cell: iCell ® Cardiomyocytes2 (FUJIFILM Cellular Dynamics)
Cell density: 16,000 cells/well
Plate: 384-well CELLAZIP™ coat-G
Assay workflow: (A) On day five, endothelin-1(ET-1) was added at concentrations ranging from 10 to 0.03 nM (n = 5) and incubated for 18 hours. (B) On day five, cells were treated with verapamil and fenofibrate at concentrations ranging from 10 μM to 0.17 nM (n = 5) and incubated for one hour, followed by the addition of 1 nM ET-1 and further incubation for 18 hours
Immunostaining: B-type natriuretic peptide (BNP) (purple), Hoechst (blue, not indicated in the figure)
Images: CellVoyager CQ1 (Yokogawa), 10x objective, (scale bar = 100 μm)
Analysis: BNP expression was quantified using image analysis software (CellPathfinder, Yokogawa) using a 10x objective image
Reference: https://doi.org/10.1242/dmm.031906
Summary
- Researchers have developed CELLAZIP™ coat-F and coat-G, COP microplates with original coating materials.
- The plates have excellent bottom flatness and storage performance at room temperature.
- Cells cultured on CELLAZIP™ showed better performance than those cultured on existing precoated microplates.
- The plates are suitable for cell-based assays with various cell types.
About ZEON Europe GmbH
ZEON is among the world's top synthetic rubber producers and a market leader in the development and production of oil-resistant specialty rubbers for automotive components. In recent years, it has established sales bases in leading countries and built a tripolar network linking Japan and the rest of Asia with North America and Europe. ZEON's history is one of innovation, and numerous awards testify to the determination with which ZEON's international sites develop products and processes.
About ELRIG (UK) Ltd.
The European Laboratory Research & Innovation Group (ELRIG) is a leading European not-for-profit organization that exists to provide outstanding scientific content to the life science community. The foundation of the organization is based on the use and application of automation, robotics and instrumentation in life science laboratories, but over time, we have evolved to respond to the needs of biopharma by developing scientific programs that focus on cutting-edge research areas that have the potential to revolutionize drug discovery.
Comprised of a global community of over 12,000 life science professionals, participating in our events, whether it be at one of our scientific conferences or one of our networking meetings, will enable any of our community to exchange information, within disciplines and across academic and biopharmaceutical organizations, on an open access basis, as all our events are free-of-charge to attend!
Our values
Our values are to always ensure the highest quality of content and that content will be made readily accessible to all, and that we will always be an inclusive organization, serving a diverse scientific network. In addition, ELRIG will always be a volunteer led organization, run by and for the life sciences community, on a not-for-profit basis.
Our purpose
ELRIG is a company whose purpose is to bring the life science and drug discovery communities together to learn, share, connect, innovate and collaborate, on an open access basis. We achieve this through the provision of world class conferences, networking events, webinars and digital content.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.
Last Updated: Nov 2, 2026